BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11554591)

  • 1. Use of prophylaxis to prevent complications of hemophilia.
    Mannucci PM; Mendolicchio L; Gringeri A
    Adv Exp Med Biol; 2001; 489():59-64. PubMed ID: 11554591
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis for hemophilia: state of the art or state of confusion?
    Gruppo RA
    J Pediatr; 1998 Jun; 132(6):915-7. PubMed ID: 9627577
    [No Abstract]   [Full Text] [Related]  

  • 3. An approach to target joint bleeding in hemophilia: prophylaxis for all or individualized treatment?
    Abshire T
    J Pediatr; 2004 Nov; 145(5):581-3. PubMed ID: 15520752
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis for severe haemophilia: clinical and economical issues.
    Fischer K; Van Den Berg M
    Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities of self-treatment in hemophilias. Preliminary report].
    Göbel U; Schulz RD
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1376-9. PubMed ID: 5055724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Errors in the treatment of children with hemophilia].
    Adamowicz-Salach A
    Wiad Lek; 1985 Jul; 38(13):961-6. PubMed ID: 3933185
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
    Berntorp E
    Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive factor replacement for management of chronic synovitis in hemophilic children.
    Miser AW; Miser JS; Newton WA
    Am J Pediatr Hematol Oncol; 1986; 8(1):66-9. PubMed ID: 3087226
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.
    Collins PW; Björkman S; Fischer K; Blanchette V; Oh M; Schroth P; Fritsch S; Casey K; Spotts G; Ewenstein BM
    J Thromb Haemost; 2010 Feb; 8(2):269-75. PubMed ID: 19943875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the benefits of prophylaxis in the management of hemophilia A.
    Hoots WK; Nugent DJ
    Thromb Haemost; 2006 Oct; 96(4):433-40. PubMed ID: 17003919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of haemophilia prophylaxis in Sweden.
    Ljung RC
    Haemophilia; 2002 Mar; 8 Suppl 2():34-7. PubMed ID: 11966851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parachutes and prophylaxis: they both work!
    White GC
    J Thromb Haemost; 2006 Jun; 4(6):1226-7. PubMed ID: 16706964
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
    Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
    Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
    Levine PH
    N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.
    Castaman G; Rocino A; Mazzucconi MG; Zanon E; Gagliano F; Molinari AC
    Blood Transfus; 2015 Oct; 13(4):631-8. PubMed ID: 26057481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects on the management of hemophilia.
    Aledort LM
    Thromb Haemost; 1995 Jul; 74(1):440-3. PubMed ID: 8578502
    [No Abstract]   [Full Text] [Related]  

  • 19. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
    Nilsson IM
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.
    Fischer K; van der Bom JG; Molho P; Negrier C; Mauser-Bunschoten EP; Roosendaal G; De Kleijn P; Grobbee DE; van den Berg HM
    Haemophilia; 2002 Nov; 8(6):745-52. PubMed ID: 12410642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.